Related Experiment Videos
Potential antineoplastics. V. Synthesis of ethyl 2,3-dioxobutyrate 2-arylhydrazono-3-thiosemicarbazones
Journal of Medicinal Chemistry
|September 1, 1970
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
FLASH radiotherapy for the treatment of symptomatic bone metastases in the thorax (FAST-02): protocol for a prospective study of a novel radiotherapy approach.
Radiation oncology (London, England)·2024
Can Rational Combination of Ultra-high Dose Rate FLASH Radiotherapy with Immunotherapy Provide a Novel Approach to Cancer Treatment?
Clinical oncology (Royal College of Radiologists (Great Britain))·2021
Model Selection for the Preclinical Development of New Drug-Radiotherapy Combinations.
Clinical oncology (Royal College of Radiologists (Great Britain))·2021
Retrospective Planning Study of Patients with Superior Sulcus Tumours Comparing Pencil Beam Scanning Protons to Volumetric-Modulated Arc Therapy.
Clinical oncology (Royal College of Radiologists (Great Britain))·2020
Rapid advances in auto-segmentation of organs at risk and target volumes in head and neck cancer.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2019
Structural and Mechanistic Studies of ADEPs Yield Potent Antibacterials and a Drug Formulation Strategy for Tuberculosis.
Journal of medicinal chemistry·2026
A 177Lu-Labeled Circular Bivalent Aptamer for PTK7-Targeting Radionuclide Therapy in Ovarian Cancer and Orthotopic Hepatoblastoma.
Journal of medicinal chemistry·2026
From Fragment Hit to Clinical Candidate: Discovery of Dual H1R/H4R Ligands with Superior Efficacy in Allergic Conjunctivitis.
Journal of medicinal chemistry·2026
Potent Anticancer Tethered Organorhodium(III) Complexes Target the Mitochondria.
Journal of medicinal chemistry·2026
Discovery of a Covalent NLRP3 LRR-Domain Probe: Reversing Renal Fibrosis via Immunometabolic Reprogramming in Organoid and Murine Models.
Journal of medicinal chemistry·2026
Lead Optimization of Multimutant KRAS Switch-II Pocket Macrocyclic Inhibitors via Isosteric Replacement to Improve ADME and Oral Exposure.
Journal of medicinal chemistry·2026